US Therapeutic Plasma Exchange Market worth $243 million by 2025 - Exclusive Report by MarketsandMarkets - Seite 2

By indication, the neurological disorders segment accounted for the largest share of the US Therapeutic Plasma Exchange Market.

On the basis of indication, the market has been segmented into neurological disorders, renal disorders, hematologic disorders, metabolic disorders, and other indications. In 2019, the neurological disorders segment accounted for the largest share of the market. Growth in this market is majorly driven by the rising prevalence and incidence of neurological diseases in the geriatric population, increasing awareness about the treatment of neurological diseases using plasma exchange, and rising investments by key players for R&D on the new application areas of therapeutic plasma exchange in the treatment of neurological disorders.

Get 10% Customization Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=87153046

On the basis of end user, the hospitals and transfusion centers segment is estimated to grow at the highest CAGR during the forecast period.

Based on end users, the US Therapeutic Plasma Exchange Market has been segmented into blood collection centers and blood component providers, hospitals and transfusion centers, and other end users. The hospitals and transfusion centers segment is estimated to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing adoption of therapeutic apheresis in the treatment of various diseases, growing indications of therapeutic apheresis, and rising awareness of apheresis as a therapy.

The prominent players in the US Therapeutic Plasma Exchange Market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), Nikkiso Co., Ltd. (Japan), Miltenyi Biotec (Germany), Medica S.p.A. (Italy), Medicap Clinic GmbH (Germany), and Infomed (Switzerland).

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting

Get Special Pricing on Bundle Reports:

https://www.marketsandmarkets.com/RequestBundleReport.asp?id=87153046

Browse Related Reports:

Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic), Application (Plasmapheresis, Plateletpheresis), Technology, End-User (Hospital, Blood Collection Center), Region - Global Forecast to 2025